Definium Therapeutics Inc. Common Shares vs Viking Holdings Ltd Ordinary Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.45 (market cap $4.59B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.46B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 7.9× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Viking Holdings Ltd Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| DFTX | VIK | |
|---|---|---|
Market Cap | $4.59B | $36.46B |
Volume | 2,103,937 | 3,461,906 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $108.26 |
52-Week Low | $10.68 | $57.08 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $38.84B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →